Skip to main content
Veterinary Medicines

Quiflor S 100 mg/ml solution for injection for cattle

Authorised
  • Marbofloxacin

Product identification

Medicine name:
Quiflor S 100 mg/ml solution for injection for cattle
Quiflor S 100 mg/ml oplossing voor injectie voor runderen
Active substance:
  • Marbofloxacin
Target species:
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Marbofloxacin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        3
        day
      • Milk
        72
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • (ID2) 250 millilitre(s): unspecified outer container with 1 Vial (Glass) with 250 millilitre(s), closed with Stopper (bromobutyl rubber`)
  • (ID1) 100 millilitre(s): unspecified outer container with 1 Vial (Glass) with 100 millilitre(s), closed with Stopper (bromobutyl rubber`)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka d.d. Novo Mesto
  • Tad Pharma GmbH
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 107425
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0303/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Greece
  • Italy
  • Lithuania
  • Netherlands
  • Portugal
  • Slovakia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 3/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."